Barely Significant

Excerpts

514,629 sentences

borderline significancep = 0.0501.0× alpha
Patients with lung or mediastinal lymph node metastases only were more likely to achieve a radiologic response compared to patients with other metastatic sites (70% vs 42%; odds ratio 3.2; 95% CI 1.09–9.15; p = 0.033), with borderline significance for CR (20% vs 8%; odds ratio 3.7; 95% CI 1.00–13.83; p = 0.050).
a significant trendp < 0.051.0× alphagold
For girls, no trend was found between the differences between the methods and the mean of both methods ( p > 0.05), while for boys, a significant trend was observed for all TBPro-DXA models ( p < 0.05), except when TBPro was estimated using the mean FFM hydration value found in our male adolescent athletes (DXA-MeanObsHF FFM ), as illustrated in Figure 1 . 4.
nominally significantP ≤ 0.051.0× alphagold
Pathway analysis performed in Metaboanalyst using all nominally significant metabolite changes ( P ≤ 0.05, FDR < 0.2) after loss of frataxin revealed effects on arginine biosynthesis, alanine metabolism, TCA cycle, taurine metabolism, and glutathione metabolism with many of the changes common among the heart, cerebellum, and mitochondria ( Supplemental Table 2A ).
a decreasing trendP > 0.051.0× alphagold
did not reach statistical significanceP > 0.051.0× alphaplainly factual
The model group exhibited significantly elevated BUN and 24h-UTP compared to controls (both P < 0.01), while both QRYSXZF and dapagliflozin treatment groups showed markedly reduced BUN and Cys-C levels versus model animals (P < 0.01), with 24h-UTP demonstrating a decreasing trend that did not reach statistical significance (P > 0.05).
an increasing trendp < 0.051.0× alphagold
Dmab-Treated Patients Show a Normal Level of Circulating γδ T Cells We monitored γδ T cells due to their reported role in maintaining bone oral cavity homeostasis, observing that, in Dmab-treated patients, circulating γδ T cells remained constant for 12 months, and then an increasing trend was evident at T18. γδ T cell level dramatically decreased at T6 after starting Zol treatment (2.4 ± 1.9 vs. 0.5 ± 0.6, p < 0.05) and remained constantly low during the rest of the observational period ( Figure 4 A).